ASAP.ST
Price:
$0.028
Market Cap:
$633.96K
Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.
Industry
Biotechnology
IPO Date
2018-09-24
Stock Exchange
STO
Ticker
ASAP.ST
According to Asarina Pharma AB (publ)’s latest financial reports and current stock price. The company's current ROE is -157.86%. This represents a change of 67.30% compared to the average of -94.36% of the last 4 quarters.
The mean historical ROE of Asarina Pharma AB (publ) over the last ten years is -219.91%. The current -157.86% ROE has changed -28.22% with respect to the historical average. Over the past ten years (40 quarters), ASAP.ST's ROE was at its highest in in the March 2017 quarter at 0%. The ROE was at its lowest in in the September 2023 quarter at -101.27%.
Average
-219.91%
Median
-143.08%
Minimum
-777.93%
Maximum
-31.47%
Discovering the peaks and valleys of Asarina Pharma AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 755.23%
Maximum Annual ROE = -31.47%
Minimum Annual Increase = -89.03%
Minimum Annual ROE = -777.93%
| Year | ROE | Change |
|---|---|---|
| 2023 | -777.93% | 755.23% |
| 2022 | -90.96% | -39.25% |
| 2021 | -149.73% | 4.65% |
| 2020 | -143.08% | 140.50% |
| 2019 | -59.49% | 89.07% |
| 2018 | -31.47% | -89.03% |
The current ROE of Asarina Pharma AB (publ) (ASAP.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-339.54%
5-year avg
-244.24%
10-year avg
-219.91%
Asarina Pharma AB (publ)’s ROE is less than Cantargia AB (publ) (108.71%), less than BioArctic AB (publ) (58.51%), greater than Ascelia Pharma AB (publ) (-102.90%), greater than Biovica International AB (publ) (-149.87%), greater than Sprint Bioscience AB (publ) (-308.32%),
| Company | ROE | Market cap |
|---|---|---|
| 108.71% | $949.70M | |
| 58.51% | $28.17B | |
| -102.90% | $347.27M | |
| -149.87% | $105.76M | |
| -308.32% | $155.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Asarina Pharma AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Asarina Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Asarina Pharma AB (publ)'s ROE?
How is the ROE calculated for Asarina Pharma AB (publ) (ASAP.ST)?
What is the highest ROE for Asarina Pharma AB (publ) (ASAP.ST)?
What is the 3-year average ROE for Asarina Pharma AB (publ) (ASAP.ST)?
What is the 5-year average ROE for Asarina Pharma AB (publ) (ASAP.ST)?
How does the current ROE for Asarina Pharma AB (publ) (ASAP.ST) compare to its historical average?